UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

The clinical landscape for AAV gene therapies

Nature reviews. Drug discovery, 2021-03, Vol.20 (3), p.173-174

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

Human mutation, 2004-06, Vol.23 (6), p.540-545

2004

Link zum Volltext

Verfügbarkeit prüfen

Association Between Genetic Variants on Chromosome 15q25 Locus and Objective Measures of Tobacco Exposure

JNCI : Journal of the National Cancer Institute, 2012-05, Vol.104 (10), p.740-748

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4575-4580

2010

Link zum Volltext

Verfügbarkeit prüfen

Genes and cigarette smoking

Addiction (Abingdon, England), 2008-06, Vol.103 (6), p.893-904

2008

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement

Pharmacogenomics, 2010-03, Vol.11 (3), p.357

2010

Link zum Volltext

Verfügbarkeit prüfen

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence

BMC public health, 2010-11, Vol.10 (1), p.680-680, Article 680

2010

Link zum Volltext

Verfügbarkeit prüfen

CHRNA3 rs1051730 Genotype and Short-Term Smoking Cessation

Nicotine & tobacco research, 2011-10, Vol.13 (10), p.982-988

2011

Link zum Volltext

Verfügbarkeit prüfen

A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans

The Journal of neuroscience, 2005-03, Vol.25 (10), p.2586-2590

2005

Link zum Volltext

Verfügbarkeit prüfen

The value of additional bevacizumab in patients with high‐risk stroma‐high colon cancer. A study within the QUASAR2 trial, an open‐label randomized phase 3 trial

Journal of surgical oncology, 2018-04, Vol.117 (5), p.1043-1048

2018

Link zum Volltext

Verfügbarkeit prüfen

Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial

Anticancer research, 2015-03, Vol.35 (3), p.1641-1645

2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of Association of OPRM1 Genotype and Smoking Cessation

Nicotine & tobacco research, 2013-03, Vol.15 (3), p.739-744

2013

Link zum Volltext

Verfügbarkeit prüfen

Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers

Nicotine & tobacco research, 2015-07, Vol.17 (7), p.855-861

2015

Link zum Volltext

Verfügbarkeit prüfen

Association of COMT Val108/158Met Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial

Cancer epidemiology, biomarkers & prevention, 2007-06, Vol.16 (6), p.1065-1069

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials

Nicotine & tobacco research, 2011-03, Vol.13 (3), p.157-167

2011

Link zum Volltext

Verfügbarkeit prüfen

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation

Nicotine & tobacco research, 2008-01, Vol.10 (1), p.231-240

2008

Link zum Volltext

Verfügbarkeit prüfen

The serotonin transporter "5-HTTLPR" polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial

Nicotine & tobacco research, 2007-02, Vol.9 (2), p.225-231

2007

Link zum Volltext

Verfügbarkeit prüfen

Association Between Nicotinic Acetylcholine Receptor Single Nucleotide Polymorphisms and Smoking Cessation

Nicotine & tobacco research, 2012-08, Vol.14 (8), p.993-997

2012

Link zum Volltext

Verfügbarkeit prüfen

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues

Addiction biology, 2008-09, Vol.13 (3-4), p.435-439

2008

Link zum Volltext

Verfügbarkeit prüfen

Neuroticism Mediates the Association of the Serotonin Transporter Gene with Lifetime Major Depression

Neuropsychobiology, 2006-02, Vol.53 (1), p.1-8

2006

Link zum Volltext

Verfügbarkeit prüfen

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial

Nicotine & tobacco research, 2009-04, Vol.11 (4), p.404-407

2009

Link zum Volltext

Verfügbarkeit prüfen

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial

Cancer epidemiology, biomarkers & prevention, 2006-02, Vol.15 (2), p.398-400

2006

Link zum Volltext

Verfügbarkeit prüfen

Identification of CYP2B6 Sequence Variants by Use of Multiplex PCR with Allele-Specific Genotyping

Clinical chemistry (Baltimore, Md.), 2004-08, Vol.50 (8), p.1372-1377

2004

Link zum Volltext

Verfügbarkeit prüfen

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses

Drug and alcohol dependence, 2008-11, Vol.98 (1), p.77-85

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(42)
Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Female
(23)
Male
(22)
Adult
(21)
Biological And Medical Sciences
(20)
Genotype
(19)
Medical Sciences
(19)
Middle Aged
(18)
Smoking - Genetics
(14)
Substance Abuse
(14)
Nicotine - Administration & Dosage
(13)
Public, Environmental & Occupational Health
(13)
Smoking Cessation
(13)
Aged
(11)
Smoking
(11)
Treatment Outcome
(11)
Polymorphism, Genetic
(10)
Smoking Cessation - Methods
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The clinical landscape for AAV gene therapies

Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

Association Between Genetic Variants on Chromosome 15q25 Locus and Objective Measures of Tobacco Exposure

Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial

Genes and cigarette smoking

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence

CHRNA3 rs1051730 Genotype and Short-Term Smoking Cessation

A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

The value of additional bevacizumab in patients with high‐risk stroma‐high colon cancer. A study within the QUASAR2 trial, an open‐label randomized phase 3 trial

Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial

Lack of Association of OPRM1 Genotype and Smoking Cessation

Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers

Association of COMT Val108/158Met Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial

Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation

The serotonin transporter "5-HTTLPR" polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial

Association Between Nicotinic Acetylcholine Receptor Single Nucleotide Polymorphisms and Smoking Cessation

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues

Neuroticism Mediates the Association of the Serotonin Transporter Gene with Lifetime Major Depression

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial

Identification of CYP2B6 Sequence Variants by Use of Multiplex PCR with Allele-Specific Genotyping

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses

Suchergebnisse filtern